Market Analysis and Insights: Global Transdermal Skin Patches Market
The global Transdermal Skin Patches market size is projected to reach US$ 52 million by 2027, from US$ 45 million in 2020, at a CAGR of 2.7% during 2021-2027.
Global Transdermal Skin Patches Scope and Segment
The global Transdermal Skin Patches market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Skin Patches market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Drug in Adhesive
Matrix
Reservoir
Vapor
Others
By the end users/application, this report covers the following segments
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
The report provides a list of all the key players in the Transdermal Skin Patches market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Transdermal Skin Patches key manufacturers in this market include:
Johnson & Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Luye Pharma Group
Hisamitsu Pharmaceutical
Mundipharma International
Purdue Pharma
The global Transdermal Skin Patches market size is projected to reach US$ 52 million by 2027, from US$ 45 million in 2020, at a CAGR of 2.7% during 2021-2027.
Global Transdermal Skin Patches Scope and Segment
The global Transdermal Skin Patches market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Skin Patches market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Drug in Adhesive
Matrix
Reservoir
Vapor
Others
By the end users/application, this report covers the following segments
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
The report provides a list of all the key players in the Transdermal Skin Patches market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Transdermal Skin Patches key manufacturers in this market include:
Johnson & Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Luye Pharma Group
Hisamitsu Pharmaceutical
Mundipharma International
Purdue Pharma
1 Transdermal Skin Patches Market Overview
1.1 Transdermal Skin Patches Product Overview
1.2 Transdermal Skin Patches Market Segment by Type
1.2.1 Drug in Adhesive
1.2.2 Matrix
1.2.3 Reservoir
1.2.4 Vapor
1.2.5 Others
1.3 Global Transdermal Skin Patches Market Size by Type
1.3.1 Global Transdermal Skin Patches Market Size Overview by Type (2016-2027)
1.3.2 Global Transdermal Skin Patches Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Transdermal Skin Patches Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Transdermal Skin Patches Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Transdermal Skin Patches Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Transdermal Skin Patches Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Transdermal Skin Patches Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Transdermal Skin Patches Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Transdermal Skin Patches Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Transdermal Skin Patches Sales Breakdown by Type (2016-2021)
1.4.2 Europe Transdermal Skin Patches Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Transdermal Skin Patches Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Transdermal Skin Patches Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Transdermal Skin Patches Sales Breakdown by Type (2016-2021)
2 Global Transdermal Skin Patches Market Competition by Company
2.1 Global Top Players by Transdermal Skin Patches Sales (2016-2021)
2.2 Global Top Players by Transdermal Skin Patches Revenue (2016-2021)
2.3 Global Top Players Transdermal Skin Patches Price (2016-2021)
2.4 Global Top Manufacturers Transdermal Skin Patches Manufacturing Base Distribution, Sales Area, Product Type
2.5 Transdermal Skin Patches Market Competitive Situation and Trends
2.5.1 Transdermal Skin Patches Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Transdermal Skin Patches Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Skin Patches as of 2020)
2.7 Date of Key Manufacturers Enter into Transdermal Skin Patches Market
2.8 Key Manufacturers Transdermal Skin Patches Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Transdermal Skin Patches Status and Outlook by Region
3.1 Global Transdermal Skin Patches Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Transdermal Skin Patches Historic Market Size by Region
3.2.1 Global Transdermal Skin Patches Sales in Volume by Region (2016-2021)
3.2.2 Global Transdermal Skin Patches Sales in Value by Region (2016-2021)
3.2.3 Global Transdermal Skin Patches Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Transdermal Skin Patches Forecasted Market Size by Region
3.3.1 Global Transdermal Skin Patches Sales in Volume by Region (2022-2027)
3.3.2 Global Transdermal Skin Patches Sales in Value by Region (2022-2027)
3.3.3 Global Transdermal Skin Patches Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Transdermal Skin Patches by Application
4.1 Transdermal Skin Patches Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Transdermal Skin Patches Market Size by Application
4.2.1 Global Transdermal Skin Patches Market Size Overview by Application (2016-2027)
4.2.2 Global Transdermal Skin Patches Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Transdermal Skin Patches Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Transdermal Skin Patches Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Transdermal Skin Patches Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Transdermal Skin Patches Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Transdermal Skin Patches Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Transdermal Skin Patches Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Transdermal Skin Patches Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Transdermal Skin Patches Sales Breakdown by Application (2016-2021)
4.3.2 Europe Transdermal Skin Patches Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Transdermal Skin Patches Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Transdermal Skin Patches Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Transdermal Skin Patches Sales Breakdown by Application (2016-2021)
5 North America Transdermal Skin Patches by Country
5.1 North America Transdermal Skin Patches Historic Market Size by Country
5.1.1 North America Transdermal Skin Patches Sales in Volume by Country (2016-2021)
5.1.2 North America Transdermal Skin Patches Sales in Value by Country (2016-2021)
5.2 North America Transdermal Skin Patches Forecasted Market Size by Country
5.2.1 North America Transdermal Skin Patches Sales in Volume by Country (2022-2027)
5.2.2 North America Transdermal Skin Patches Sales in Value by Country (2022-2027)
6 Europe Transdermal Skin Patches by Country
6.1 Europe Transdermal Skin Patches Historic Market Size by Country
6.1.1 Europe Transdermal Skin Patches Sales in Volume by Country (2016-2021)
6.1.2 Europe Transdermal Skin Patches Sales in Value by Country (2016-2021)
6.2 Europe Transdermal Skin Patches Forecasted Market Size by Country
6.2.1 Europe Transdermal Skin Patches Sales in Volume by Country (2022-2027)
6.2.2 Europe Transdermal Skin Patches Sales in Value by Country (2022-2027)
7 Asia-Pacific Transdermal Skin Patches by Region
7.1 Asia-Pacific Transdermal Skin Patches Historic Market Size by Region
7.1.1 Asia-Pacific Transdermal Skin Patches Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Transdermal Skin Patches Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Transdermal Skin Patches Forecasted Market Size by Region
7.2.1 Asia-Pacific Transdermal Skin Patches Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Transdermal Skin Patches Sales in Value by Region (2022-2027)
8 Latin America Transdermal Skin Patches by Country
8.1 Latin America Transdermal Skin Patches Historic Market Size by Country
8.1.1 Latin America Transdermal Skin Patches Sales in Volume by Country (2016-2021)
8.1.2 Latin America Transdermal Skin Patches Sales in Value by Country (2016-2021)
8.2 Latin America Transdermal Skin Patches Forecasted Market Size by Country
8.2.1 Latin America Transdermal Skin Patches Sales in Volume by Country (2022-2027)
8.2.2 Latin America Transdermal Skin Patches Sales in Value by Country (2022-2027)
9 Middle East and Africa Transdermal Skin Patches by Country
9.1 Middle East and Africa Transdermal Skin Patches Historic Market Size by Country
9.1.1 Middle East and Africa Transdermal Skin Patches Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Transdermal Skin Patches Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Transdermal Skin Patches Forecasted Market Size by Country
9.2.1 Middle East and Africa Transdermal Skin Patches Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Transdermal Skin Patches Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Transdermal Skin Patches Business
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Corporation Information
10.1.2 Johnson & Johnson Introduction and Business Overview
10.1.3 Johnson & Johnson Transdermal Skin Patches Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Johnson & Johnson Transdermal Skin Patches Products Offered
10.1.5 Johnson & Johnson Recent Development
10.2 Novartis AG
10.2.1 Novartis AG Corporation Information
10.2.2 Novartis AG Introduction and Business Overview
10.2.3 Novartis AG Transdermal Skin Patches Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Johnson & Johnson Transdermal Skin Patches Products Offered
10.2.5 Novartis AG Recent Development
10.3 Mylan N.V.
10.3.1 Mylan N.V. Corporation Information
10.3.2 Mylan N.V. Introduction and Business Overview
10.3.3 Mylan N.V. Transdermal Skin Patches Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Mylan N.V. Transdermal Skin Patches Products Offered
10.3.5 Mylan N.V. Recent Development
10.4 Teva Pharmaceutical Industries
10.4.1 Teva Pharmaceutical Industries Corporation Information
10.4.2 Teva Pharmaceutical Industries Introduction and Business Overview
10.4.3 Teva Pharmaceutical Industries Transdermal Skin Patches Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Teva Pharmaceutical Industries Transdermal Skin Patches Products Offered
10.4.5 Teva Pharmaceutical Industries Recent Development
10.5 Luye Pharma Group
10.5.1 Luye Pharma Group Corporation Information
10.5.2 Luye Pharma Group Introduction and Business Overview
10.5.3 Luye Pharma Group Transdermal Skin Patches Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Luye Pharma Group Transdermal Skin Patches Products Offered
10.5.5 Luye Pharma Group Recent Development
10.6 Hisamitsu Pharmaceutical
10.6.1 Hisamitsu Pharmaceutical Corporation Information
10.6.2 Hisamitsu Pharmaceutical Introduction and Business Overview
10.6.3 Hisamitsu Pharmaceutical Transdermal Skin Patches Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Hisamitsu Pharmaceutical Transdermal Skin Patches Products Offered
10.6.5 Hisamitsu Pharmaceutical Recent Development
10.7 Mundipharma International
10.7.1 Mundipharma International Corporation Information
10.7.2 Mundipharma International Introduction and Business Overview
10.7.3 Mundipharma International Transdermal Skin Patches Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Mundipharma International Transdermal Skin Patches Products Offered
10.7.5 Mundipharma International Recent Development
10.8 Purdue Pharma
10.8.1 Purdue Pharma Corporation Information
10.8.2 Purdue Pharma Introduction and Business Overview
10.8.3 Purdue Pharma Transdermal Skin Patches Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Purdue Pharma Transdermal Skin Patches Products Offered
10.8.5 Purdue Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Transdermal Skin Patches Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Transdermal Skin Patches Industrial Chain Analysis
11.4 Transdermal Skin Patches Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Transdermal Skin Patches Distributors
12.3 Transdermal Skin Patches Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Transdermal Skin Patches Product Overview
1.2 Transdermal Skin Patches Market Segment by Type
1.2.1 Drug in Adhesive
1.2.2 Matrix
1.2.3 Reservoir
1.2.4 Vapor
1.2.5 Others
1.3 Global Transdermal Skin Patches Market Size by Type
1.3.1 Global Transdermal Skin Patches Market Size Overview by Type (2016-2027)
1.3.2 Global Transdermal Skin Patches Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Transdermal Skin Patches Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Transdermal Skin Patches Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Transdermal Skin Patches Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Transdermal Skin Patches Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Transdermal Skin Patches Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Transdermal Skin Patches Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Transdermal Skin Patches Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Transdermal Skin Patches Sales Breakdown by Type (2016-2021)
1.4.2 Europe Transdermal Skin Patches Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Transdermal Skin Patches Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Transdermal Skin Patches Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Transdermal Skin Patches Sales Breakdown by Type (2016-2021)
2 Global Transdermal Skin Patches Market Competition by Company
2.1 Global Top Players by Transdermal Skin Patches Sales (2016-2021)
2.2 Global Top Players by Transdermal Skin Patches Revenue (2016-2021)
2.3 Global Top Players Transdermal Skin Patches Price (2016-2021)
2.4 Global Top Manufacturers Transdermal Skin Patches Manufacturing Base Distribution, Sales Area, Product Type
2.5 Transdermal Skin Patches Market Competitive Situation and Trends
2.5.1 Transdermal Skin Patches Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Transdermal Skin Patches Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Skin Patches as of 2020)
2.7 Date of Key Manufacturers Enter into Transdermal Skin Patches Market
2.8 Key Manufacturers Transdermal Skin Patches Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Transdermal Skin Patches Status and Outlook by Region
3.1 Global Transdermal Skin Patches Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Transdermal Skin Patches Historic Market Size by Region
3.2.1 Global Transdermal Skin Patches Sales in Volume by Region (2016-2021)
3.2.2 Global Transdermal Skin Patches Sales in Value by Region (2016-2021)
3.2.3 Global Transdermal Skin Patches Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Transdermal Skin Patches Forecasted Market Size by Region
3.3.1 Global Transdermal Skin Patches Sales in Volume by Region (2022-2027)
3.3.2 Global Transdermal Skin Patches Sales in Value by Region (2022-2027)
3.3.3 Global Transdermal Skin Patches Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Transdermal Skin Patches by Application
4.1 Transdermal Skin Patches Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Transdermal Skin Patches Market Size by Application
4.2.1 Global Transdermal Skin Patches Market Size Overview by Application (2016-2027)
4.2.2 Global Transdermal Skin Patches Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Transdermal Skin Patches Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Transdermal Skin Patches Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Transdermal Skin Patches Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Transdermal Skin Patches Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Transdermal Skin Patches Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Transdermal Skin Patches Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Transdermal Skin Patches Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Transdermal Skin Patches Sales Breakdown by Application (2016-2021)
4.3.2 Europe Transdermal Skin Patches Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Transdermal Skin Patches Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Transdermal Skin Patches Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Transdermal Skin Patches Sales Breakdown by Application (2016-2021)
5 North America Transdermal Skin Patches by Country
5.1 North America Transdermal Skin Patches Historic Market Size by Country
5.1.1 North America Transdermal Skin Patches Sales in Volume by Country (2016-2021)
5.1.2 North America Transdermal Skin Patches Sales in Value by Country (2016-2021)
5.2 North America Transdermal Skin Patches Forecasted Market Size by Country
5.2.1 North America Transdermal Skin Patches Sales in Volume by Country (2022-2027)
5.2.2 North America Transdermal Skin Patches Sales in Value by Country (2022-2027)
6 Europe Transdermal Skin Patches by Country
6.1 Europe Transdermal Skin Patches Historic Market Size by Country
6.1.1 Europe Transdermal Skin Patches Sales in Volume by Country (2016-2021)
6.1.2 Europe Transdermal Skin Patches Sales in Value by Country (2016-2021)
6.2 Europe Transdermal Skin Patches Forecasted Market Size by Country
6.2.1 Europe Transdermal Skin Patches Sales in Volume by Country (2022-2027)
6.2.2 Europe Transdermal Skin Patches Sales in Value by Country (2022-2027)
7 Asia-Pacific Transdermal Skin Patches by Region
7.1 Asia-Pacific Transdermal Skin Patches Historic Market Size by Region
7.1.1 Asia-Pacific Transdermal Skin Patches Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Transdermal Skin Patches Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Transdermal Skin Patches Forecasted Market Size by Region
7.2.1 Asia-Pacific Transdermal Skin Patches Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Transdermal Skin Patches Sales in Value by Region (2022-2027)
8 Latin America Transdermal Skin Patches by Country
8.1 Latin America Transdermal Skin Patches Historic Market Size by Country
8.1.1 Latin America Transdermal Skin Patches Sales in Volume by Country (2016-2021)
8.1.2 Latin America Transdermal Skin Patches Sales in Value by Country (2016-2021)
8.2 Latin America Transdermal Skin Patches Forecasted Market Size by Country
8.2.1 Latin America Transdermal Skin Patches Sales in Volume by Country (2022-2027)
8.2.2 Latin America Transdermal Skin Patches Sales in Value by Country (2022-2027)
9 Middle East and Africa Transdermal Skin Patches by Country
9.1 Middle East and Africa Transdermal Skin Patches Historic Market Size by Country
9.1.1 Middle East and Africa Transdermal Skin Patches Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Transdermal Skin Patches Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Transdermal Skin Patches Forecasted Market Size by Country
9.2.1 Middle East and Africa Transdermal Skin Patches Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Transdermal Skin Patches Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Transdermal Skin Patches Business
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Corporation Information
10.1.2 Johnson & Johnson Introduction and Business Overview
10.1.3 Johnson & Johnson Transdermal Skin Patches Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Johnson & Johnson Transdermal Skin Patches Products Offered
10.1.5 Johnson & Johnson Recent Development
10.2 Novartis AG
10.2.1 Novartis AG Corporation Information
10.2.2 Novartis AG Introduction and Business Overview
10.2.3 Novartis AG Transdermal Skin Patches Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Johnson & Johnson Transdermal Skin Patches Products Offered
10.2.5 Novartis AG Recent Development
10.3 Mylan N.V.
10.3.1 Mylan N.V. Corporation Information
10.3.2 Mylan N.V. Introduction and Business Overview
10.3.3 Mylan N.V. Transdermal Skin Patches Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Mylan N.V. Transdermal Skin Patches Products Offered
10.3.5 Mylan N.V. Recent Development
10.4 Teva Pharmaceutical Industries
10.4.1 Teva Pharmaceutical Industries Corporation Information
10.4.2 Teva Pharmaceutical Industries Introduction and Business Overview
10.4.3 Teva Pharmaceutical Industries Transdermal Skin Patches Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Teva Pharmaceutical Industries Transdermal Skin Patches Products Offered
10.4.5 Teva Pharmaceutical Industries Recent Development
10.5 Luye Pharma Group
10.5.1 Luye Pharma Group Corporation Information
10.5.2 Luye Pharma Group Introduction and Business Overview
10.5.3 Luye Pharma Group Transdermal Skin Patches Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Luye Pharma Group Transdermal Skin Patches Products Offered
10.5.5 Luye Pharma Group Recent Development
10.6 Hisamitsu Pharmaceutical
10.6.1 Hisamitsu Pharmaceutical Corporation Information
10.6.2 Hisamitsu Pharmaceutical Introduction and Business Overview
10.6.3 Hisamitsu Pharmaceutical Transdermal Skin Patches Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Hisamitsu Pharmaceutical Transdermal Skin Patches Products Offered
10.6.5 Hisamitsu Pharmaceutical Recent Development
10.7 Mundipharma International
10.7.1 Mundipharma International Corporation Information
10.7.2 Mundipharma International Introduction and Business Overview
10.7.3 Mundipharma International Transdermal Skin Patches Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Mundipharma International Transdermal Skin Patches Products Offered
10.7.5 Mundipharma International Recent Development
10.8 Purdue Pharma
10.8.1 Purdue Pharma Corporation Information
10.8.2 Purdue Pharma Introduction and Business Overview
10.8.3 Purdue Pharma Transdermal Skin Patches Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Purdue Pharma Transdermal Skin Patches Products Offered
10.8.5 Purdue Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Transdermal Skin Patches Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Transdermal Skin Patches Industrial Chain Analysis
11.4 Transdermal Skin Patches Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Transdermal Skin Patches Distributors
12.3 Transdermal Skin Patches Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
